These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

560 related articles for article (PubMed ID: 30280646)

  • 1. Prediction of Susceptibility to First-Line Tuberculosis Drugs by DNA Sequencing.
    ; Allix-Béguec C; Arandjelovic I; Bi L; Beckert P; Bonnet M; Bradley P; Cabibbe AM; Cancino-Muñoz I; Caulfield MJ; Chaiprasert A; Cirillo DM; Clifton DA; Comas I; Crook DW; De Filippo MR; de Neeling H; Diel R; Drobniewski FA; Faksri K; Farhat MR; Fleming J; Fowler P; Fowler TA; Gao Q; Gardy J; Gascoyne-Binzi D; Gibertoni-Cruz AL; Gil-Brusola A; Golubchik T; Gonzalo X; Grandjean L; He G; Guthrie JL; Hoosdally S; Hunt M; Iqbal Z; Ismail N; Johnston J; Khanzada FM; Khor CC; Kohl TA; Kong C; Lipworth S; Liu Q; Maphalala G; Martinez E; Mathys V; Merker M; Miotto P; Mistry N; Moore DAJ; Murray M; Niemann S; Omar SV; Ong RT; Peto TEA; Posey JE; Prammananan T; Pym A; Rodrigues C; Rodrigues M; Rodwell T; Rossolini GM; Sánchez Padilla E; Schito M; Shen X; Shendure J; Sintchenko V; Sloutsky A; Smith EG; Snyder M; Soetaert K; Starks AM; Supply P; Suriyapol P; Tahseen S; Tang P; Teo YY; Thuong TNT; Thwaites G; Tortoli E; van Soolingen D; Walker AS; Walker TM; Wilcox M; Wilson DJ; Wyllie D; Yang Y; Zhang H; Zhao Y; Zhu B
    N Engl J Med; 2018 Oct; 379(15):1403-1415. PubMed ID: 30280646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis.
    Al-Mutairi NM; Ahmad S; Mokaddas E; Eldeen HS; Joseph S
    BMC Infect Dis; 2019 Jan; 19(1):3. PubMed ID: 30606116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole-genome sequencing in drug susceptibility testing of Mycobacterium tuberculosis in routine practice in Lyon, France.
    Genestet C; Hodille E; Berland JL; Ginevra C; Bryant JE; Ader F; Lina G; Dumitrescu O;
    Int J Antimicrob Agents; 2020 Apr; 55(4):105912. PubMed ID: 31991222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of whole genome sequencing versus phenotypic (MGIT) and commercial molecular tests for detection of drug-resistant Mycobacterium tuberculosis isolated from patients in Brazil and Mozambique.
    Feliciano CS; Namburete EI; Rodrigues Plaça J; Peronni K; Dippenaar A; Warren RM; Silva WA; Bollela VR
    Tuberculosis (Edinb); 2018 May; 110():59-67. PubMed ID: 29779775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Diagnostic Algorithm To Investigate Pyrazinamide and Ethambutol Resistance in Rifampin-Resistant Mycobacterium tuberculosis Isolates in a Low-Incidence Setting.
    Andres S; Gröschel MI; Hillemann D; Merker M; Niemann S; Kranzer K
    Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30455227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a bacteriophage-based assay (phage amplified biologically assay) as a rapid screen for resistance to isoniazid, ethambutol, streptomycin, pyrazinamide, and ciprofloxacin among clinical isolates of Mycobacterium tuberculosis.
    Eltringham IJ; Wilson SM; Drobniewski FA
    J Clin Microbiol; 1999 Nov; 37(11):3528-32. PubMed ID: 10523547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of correlation between embB mutation and ethambutol MIC in Mycobacterium tuberculosis clinical isolates from China.
    Shi R; Zhang J; Otomo K; Zhang G; Sugawara I
    Antimicrob Agents Chemother; 2007 Dec; 51(12):4515-7. PubMed ID: 17846128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of whole-genome sequencing to predict Mycobacterium tuberculosis drug resistance in Shanghai, China.
    Wu X; Gao R; Shen X; Guo Y; Yang J; Wu Z; Tan G; Wang H; Yu F
    Int J Infect Dis; 2020 Jul; 96():48-53. PubMed ID: 32339720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular detection of mutations associated with first- and second-line drug resistance compared with conventional drug susceptibility testing of Mycobacterium tuberculosis.
    Campbell PJ; Morlock GP; Sikes RD; Dalton TL; Metchock B; Starks AM; Hooks DP; Cowan LS; Plikaytis BB; Posey JE
    Antimicrob Agents Chemother; 2011 May; 55(5):2032-41. PubMed ID: 21300839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency of embB codon 306 mutations in ethambutol-susceptible and -resistant clinical Mycobacterium tuberculosis isolates in Kuwait.
    Ahmad S; Jaber AA; Mokaddas E
    Tuberculosis (Edinb); 2007 Mar; 87(2):123-9. PubMed ID: 17289435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of gene mutations associated with isoniazid, rifampicin and ethambutol resistance among Mycobacterium tuberculosis isolates from Ethiopia.
    Tessema B; Beer J; Emmrich F; Sack U; Rodloff AC
    BMC Infect Dis; 2012 Feb; 12():37. PubMed ID: 22325147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of smear-positive samples to assess the PCR-based genotype MTBDR assay for rapid, direct detection of the Mycobacterium tuberculosis complex as well as its resistance to isoniazid and rifampin.
    Somoskovi A; Dormandy J; Mitsani D; Rivenburg J; Salfinger M
    J Clin Microbiol; 2006 Dec; 44(12):4459-63. PubMed ID: 17035488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conventional and molecular determination of drug resistance in Mycobacterium tuberculosis and Mycobacterium bovis isolates in cattle.
    Sweetline Anne N; Ronald BSM; Senthil Kumar TMA; Thangavelu A
    Tuberculosis (Edinb); 2019 Jan; 114():113-118. PubMed ID: 30711149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of the rifampin monoresistance mechanism in Mycobacterium tuberculosis.
    Pang Y; Lu J; Wang Y; Song Y; Wang S; Zhao Y
    Antimicrob Agents Chemother; 2013 Feb; 57(2):893-900. PubMed ID: 23208715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid, automated, nonradiometric susceptibility testing of Mycobacterium tuberculosis complex to four first-line antituberculous drugs used in standard short-course chemotherapy.
    Johansen IS; Thomsen VØ; Marjamäki M; Sosnovskaja A; Lundgren B
    Diagn Microbiol Infect Dis; 2004 Oct; 50(2):103-7. PubMed ID: 15474318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of line probe assay to BACTEC MGIT 960 system for susceptibility testing of first and second-line anti-tuberculosis drugs in a referral laboratory in South Africa.
    Maningi NE; Malinga LA; Antiabong JF; Lekalakala RM; Mbelle NM
    BMC Infect Dis; 2017 Dec; 17(1):795. PubMed ID: 29282012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigating resistance in clinical Mycobacterium tuberculosis complex isolates with genomic and phenotypic antimicrobial susceptibility testing: a multicentre observational study.
    Finci I; Albertini A; Merker M; Andres S; Bablishvili N; Barilar I; Cáceres T; Crudu V; Gotuzzo E; Hapeela N; Hoffmann H; Hoogland C; Kohl TA; Kranzer K; Mantsoki A; Maurer FP; Nicol MP; Noroc E; Plesnik S; Rodwell T; Ruhwald M; Savidge T; Salfinger M; Streicher E; Tukvadze N; Warren R; Zemanay W; Zurek A; Niemann S; Denkinger CM
    Lancet Microbe; 2022 Sep; 3(9):e672-e682. PubMed ID: 35907429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minor contribution of mutations at iniA codon 501 and embC-embA intergenic region in ethambutol-resistant clinical Mycobacterium tuberculosis isolates in Kuwait.
    Jaber AA; Ahmad S; Mokaddas E
    Ann Clin Microbiol Antimicrob; 2009 Jan; 8():2. PubMed ID: 19146672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of isoniazid, streptomycin and ethambutol resistance in Mycobacterium tuberculosis isolates from Morocco.
    Chaoui I; Sabouni R; Kourout M; Jordaan AM; Lahlou O; Elouad R; Akrim M; Victor TC; El Mzibri M
    J Infect Dev Ctries; 2009 May; 3(4):278-84. PubMed ID: 19759491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular identification of mutations conferring resistance to rifampin, isoniazid and pyrazinamide among
    Haratiasl AA; Hamzelou G; Amini S; Kardan-Yamchi J; Haeili M; Heidari F; Feizabadi MM
    J Chemother; 2020 Apr; 32(2):75-82. PubMed ID: 32009582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.